Literature DB >> 23046136

The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling.

Sophie E Broughton1, Urmi Dhagat, Timothy R Hercus, Tracy L Nero, Michele A Grimbaldeston, Claudine S Bonder, Angel F Lopez, Michael W Parker.   

Abstract

Granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and IL-5 are members of a discrete family of cytokines that regulates the growth, differentiation, migration and effector function activities of many hematopoietic cells and immunocytes. These cytokines are involved in normal responses to infectious agents, bridging innate and adaptive immunity. However, in certain cases, the overexpression of these cytokines or their receptors can lead to excessive or aberrant initiation of signaling resulting in pathological conditions, with chronic inflammatory diseases and myeloid leukemias the most notable examples. Recent crystal structures of the GM-CSF receptor ternary complex and the IL-5 binary complex have revealed new paradigms of cytokine receptor activation. Together with a wealth of associated structure-function studies, they have significantly enhanced our understanding of how these receptors recognize cytokines and initiate signals across cell membranes. Importantly, these structures provide opportunities for structure-based approaches for the discovery of novel and disease-specific therapeutics. In addition, recent biochemical evidence has suggested that the GM-CSF/IL-3/IL-5 receptor family is capable of interacting productively with other membrane proteins at the cell surface. Such interactions may afford additional or unique biological activities and might be harnessed for selective modulation of the function of these receptors in disease.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23046136     DOI: 10.1111/j.1600-065X.2012.01164.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  77 in total

Review 1.  Regulation of present and future development by maternal regulatory signals acting on the embryo during the morula to blastocyst transition - insights from the cow.

Authors:  Peter J Hansen; Paula Tríbulo
Journal:  Biol Reprod       Date:  2019-09-01       Impact factor: 4.285

Review 2.  Role of the β Common (βc) Family of Cytokines in Health and Disease.

Authors:  Timothy R Hercus; Winnie L T Kan; Sophie E Broughton; Denis Tvorogov; Hayley S Ramshaw; Jarrod J Sandow; Tracy L Nero; Urmi Dhagat; Emma J Thompson; Karen S Cheung Tung Shing; Duncan R McKenzie; Nicholas J Wilson; Catherine M Owczarek; Gino Vairo; Andrew D Nash; Vinay Tergaonkar; Timothy Hughes; Paul G Ekert; Michael S Samuel; Claudine S Bonder; Michele A Grimbaldeston; Michael W Parker; Angel F Lopez
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

3.  CCR2 deficiency leads to increased eosinophils, alternative macrophage activation, and type 2 cytokine expression in adipose tissue.

Authors:  W Reid Bolus; Dario A Gutierrez; Arion J Kennedy; Emily K Anderson-Baucum; Alyssa H Hasty
Journal:  J Leukoc Biol       Date:  2015-05-01       Impact factor: 4.962

4.  IL-3 promotes the development of experimental autoimmune encephalitis.

Authors:  Kerstin Renner; Sonja Hellerbrand; Fabian Hermann; Christine Riedhammer; Yvonne Talke; Gabriela Schiechl; Manuel Rodriguez Gomez; Simone Kutzi; Dagmar Halbritter; Nicole Goebel; Hilke Brühl; Robert Weissert; Matthias Mack
Journal:  JCI Insight       Date:  2016-10-06

5.  Murine Th9 cells promote the survival of myeloid dendritic cells in cancer immunotherapy.

Authors:  Jungsun Park; Haiyan Li; Mingjun Zhang; Yong Lu; Bangxing Hong; Yuhuan Zheng; Jin He; Jing Yang; Jianfei Qian; Qing Yi
Journal:  Cancer Immunol Immunother       Date:  2014-05-20       Impact factor: 6.968

6.  Ultrasound-mediated delivery of miRNA-122 and anti-miRNA-21 therapeutically immunomodulates murine hepatocellular carcinoma in vivo.

Authors:  Jennifer C Wischhusen; Sayan Mullick Chowdhury; Taehwa Lee; Huaijun Wang; Sunitha Bachawal; Rammohan Devulapally; Rayhaneh Afjei; Uday Kumar Sukumar; Ramasamy Paulmurugan
Journal:  J Control Release       Date:  2020-01-29       Impact factor: 9.776

7.  IL-3 synergises with basophil-derived IL-4 and IL-13 to promote the alternative activation of human monocytes.

Authors:  Francesco Borriello; Michele Longo; Rosa Spinelli; Antonio Pecoraro; Francescopaolo Granata; Rosaria Ilaria Staiano; Stefania Loffredo; Giuseppe Spadaro; Francesco Beguinot; John Schroeder; Gianni Marone
Journal:  Eur J Immunol       Date:  2015-04-28       Impact factor: 5.532

8.  IL-3 contributes to development of lupus nephritis in MRL/lpr mice.

Authors:  Kerstin Renner; Fabian Johannes Hermann; Kathrin Schmidbauer; Yvonne Talke; Manuel Rodriguez Gomez; Gabriela Schiechl; Jens Schlossmann; Hilke Brühl; Hans-Joachim Anders; Matthias Mack
Journal:  Kidney Int       Date:  2015-07-01       Impact factor: 10.612

9.  The RNFT2/IL-3Rα axis regulates IL-3 signaling and innate immunity.

Authors:  Yao Tong; Travis B Lear; John Evankovich; Yanwen Chen; James D Londino; Michael M Myerburg; Yingze Zhang; Iulia D Popescu; John F McDyer; Bryan J McVerry; Karina C Lockwood; Michael J Jurczak; Yuan Liu; Bill B Chen
Journal:  JCI Insight       Date:  2020-02-13

10.  Insights into immune structure, recognition, and signaling.

Authors:  K Christopher Garcia
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.